logo

EUDA

EUDA Health·NASDAQ
--
--(--)
--
--(--)
0.39 / 10
Underperform

The company's financial health is concerning: key metrics include a fixed assets turnover ratio of 31.47 (group 4, bearish), an interest coverage ratio of 27.58 (group 1, mixed), and a long-term debt to working capital ratio of 7.24 (group 3, bearish). Revenue growth is strong at 60.23% YoY, but this is offset by inventory turnover days of 9.96 and a quick ratio of 0.21, indicating liquidity issues. Net profit growth is 92.85% YoY, yet the overall fundamental score is just 0.4/10, signaling substantial operational and balance-sheet risks.

Fundamental(0.39)SentimentTechnical

Analysis Checks(4/10)

Total operating revenue (YoY growth rate %)
Value60.23
Score3/3
Weight-40.22%
1M Return4.49%
Quick ratio
Value0.21
Score1/3
Weight19.06%
1M Return-2.86%
Total profit (YoY growth rate %)
Value92.80
Score1/3
Weight27.51%
1M Return-4.59%
Net cash flow from operating activities (YoY growth rate %)
Value3.43
Score0/3
Weight33.16%
1M Return-5.07%
Fixed assets turnover ratio
Value31.47
Score0/3
Weight32.91%
1M Return-5.85%
Long-term debt to working capital ratio (%)
Value7.24
Score0/3
Weight26.65%
1M Return-4.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight10.99%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value60.23
Score3/3
Weight-40.22%
1M Return4.49%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value92.85
Score1/3
Weight29.18%
1M Return-5.11%
Inventory turnover days
Value9.96
Score3/3
Weight0.99%
1M Return-0.14%
Is EUDA fundamentally strong?
  • EUDA scores 0.39/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 4.65% net margin, 154.66 P/E ratio, -11.07 P/B ratio, and 114.29% earnings growth, these metrics solidify its Underperform investment rating.